Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model

Pharmacologic strategies have provided modest improvement in the devastating muscle-wasting disease, Duchenne muscular dystrophy (DMD). Pre-clinical gene therapy studies have shown promise in the mdx mouse model; however, studies conducted after disease onset fall short of fully correcting muscle st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodino-Klapac, Louise R., Janssen, Paul M. L., Shontz, Kimberly M., Canan, Benjamin, Montgomery, Chrystal L., Griffin, Danielle, Heller, Kristin, Schmelzer, Leah, Handy, Chalonda, Clark, K. Reed, Sahenk, Zarife, Mendell, Jerry R., Kaspar, Brian K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2013
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895965/
https://ncbi.nlm.nih.gov/pubmed/23863459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddt342
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares